Pantakan, Norsa .
HRN: 23-84-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2023
CEFUROXIME 1.5GM (VIAL)
10/08/2023
10/09/2023
IV
1.5g
PTOR
Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes